Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-349516
Filing Date
2012-08-10
Accepted
2012-08-10 13:33:06
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d359739d10q.htm 10-Q 392077
2 EX-31.1 d359739dex311.htm EX-31.1 5813
3 EX-31.2 d359739dex312.htm EX-31.2 5788
4 EX-32.1 d359739dex321.htm EX-32.1 3781
5 EX-32.2 d359739dex322.htm EX-32.2 3741
  Complete submission text file 0001193125-12-349516.txt   3168289

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20120630.xml EX-101.INS 456246
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20120630.xsd EX-101.SCH 24282
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20120630_cal.xml EX-101.CAL 37127
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20120630_def.xml EX-101.DEF 123971
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20120630_lab.xml EX-101.LAB 230930
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20120630_pre.xml EX-101.PRE 172263
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 121023843
SIC: 2834 Pharmaceutical Preparations